Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin in Chronic Hemodialysis
NCT02261025Completed
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Jan 2008
- Primary completion
- Sep 2014
- Modality
- Orthosteric Ligands
01
Overview
Open-label trial of aspirin in cardiovascular disease (CVD) (2 arms), sponsored by Shanghai Jiao Tong University School of Medicine. Primary endpoint: Survival rate at 5 years. Started Jan 2008; status: completed.
02
Drugs
aspirin
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT02261025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02261025.